Pruritus clinical trials

Explore recruiting pruritus clinical trials.

Recruiting pruritus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pruritus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Master protocol of two randomized, double blind, placebo-controlled, multi-center, parallel group studies to evaluate the efficacy and safety of dupilumab in adult patients with chronic pruritus of unknown origin (CPUO)

Hungary, Italy, Spain, Poland, Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Biliary Cholangitis (VANTAGE)

Germany, France, Italy, Netherlands, Spain, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Czechia, Belgium, Spain, Hungary, Italy, Netherlands +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Risk-benefit analysis of intrathecal morphine administration to patients undergoing surgical treatment of proximal femoral fracture (monocentric, single-blinded, randomized clinical study compared to standard treatment)

Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicentre, randomised, double-blind, placebo-controlled, 12-week parallel-group trial to evaluate the efficacy and safety of oral BP1.7881 in adult patients with moderate-to-severe atopic dermatitis

Germany, Poland, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Double-Blind, Randomized, Placebo-Controlled, Phase 1b, Pharmacodynamic Trial of TEV-56192 Following a Single Intravenous Administration in Healthy Participants

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Pruritus trials by city

Pruritus in Toronto Pruritus in Vancouver Pruritus in Montreal Pruritus in Calgary Pruritus in Edmonton Pruritus in Ottawa Pruritus in Winnipeg Pruritus in Quebec City Pruritus in Hamilton Pruritus in Kitchener Pruritus in London Pruritus in Halifax Pruritus in New York Pruritus in Los Angeles Pruritus in Chicago Pruritus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease